<DOC>
	<DOCNO>NCT02331511</DOCNO>
	<brief_summary>The purpose study determine whether Aspirin Clopidogrel effective prevention venous obstruction implantation cardiac pacemaker defibrillator .</brief_summary>
	<brief_title>Prevention Venous Obstruction After Implantation Cardiac Pacemaker Defibrillator</brief_title>
	<detailed_description>There grow number endocardial permanent pacemaker ( PPM ) implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy ( CRT ) device . Asymptomatic obstruction access vein report high incidence ( 30-50 % ) study . This complication cause difficulty follow procedure device upgrade . The purpose study determine whether Aspirin Clopidogrel effective prevention venous obstruction implantation cardiac pacemaker defibrillator .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>patient refer first implantation pacemaker , implantable cardiac defibrillator , cardiac synchronization therapy device history malignancy history coagulopathy platelet disorder history venous thromboembolism history gastrointestinal hemorrhage active gastroduodenal ulcer past 6 month history chronic kidney disorder serum creatinine 1.5 mg/dl patient anticoagulant antithrombotic drug must dual antiplatelet therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>